Literature DB >> 3783318

Autosomal dominance in a late-onset motor neuron disease in the mouse.

A Messer, L Flaherty.   

Abstract

A late-onset neurological disease has been identified in a substrain of C57Bl/6 mice. The disorder is characterized by hindlimb weakness and ataxia starting at 5-11 months of age, progressing to severe spastic paralysis of all limbs, with premature death. Histopathology reveals degeneration of upper and lower motoneurons. Both sexes are affected; the mice are fertile, although breeding efficiency is reduced. In outcrosses to wild-type, symptoms have been observed in all obligate heterozygotes, with a similar age range for onset to that of homozygotes. We have designated this autosomal dominant disorder Motor neuron degeneration (Mnd).

Entities:  

Mesh:

Year:  1986        PMID: 3783318     DOI: 10.3109/01677068609106858

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  8 in total

1.  Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. A model for neuronal ceroid lipofuscinosis.

Authors:  C A Pardo; B A Rabin; D N Palmer; D L Price
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

2.  Seizure susceptibility, phenotype, and resultant growth delay in the nclf and mnd mouse models of neuronal ceroid lipofuscinoses.

Authors:  Elizabeth Kriscenski-Perry; Attila D Kovács; David A Pearce
Journal:  J Child Neurol       Date:  2013-07-09       Impact factor: 1.987

3.  Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment.

Authors:  J D Cooper; A Messer; A K Feng; J Chua-Couzens; W C Mobley
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

Review 4.  Progress in the Development of Small Molecule Therapeutics for the Treatment of Neuronal Ceroid Lipofuscinoses (NCLs).

Authors:  Nihar Kinarivala; Paul C Trippier
Journal:  J Med Chem       Date:  2015-11-24       Impact factor: 7.446

5.  The neuronal ceroid lipofuscinosis Cln8 gene expression is developmentally regulated in mouse brain and up-regulated in the hippocampal kindling model of epilepsy.

Authors:  Liina Lonka; Antti Aalto; Outi Kopra; Mervi Kuronen; Zaal Kokaia; Mart Saarma; Anna-Elina Lehesjoki
Journal:  BMC Neurosci       Date:  2005-04-13       Impact factor: 3.288

Review 6.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases.

Authors:  James C Dodge
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

Review 7.  Modeling Rare Human Disorders in Mice: The Finnish Disease Heritage.

Authors:  Tomáš Zárybnický; Anne Heikkinen; Salla M Kangas; Marika Karikoski; Guillermo Antonio Martínez-Nieto; Miia H Salo; Johanna Uusimaa; Reetta Vuolteenaho; Reetta Hinttala; Petra Sipilä; Satu Kuure
Journal:  Cells       Date:  2021-11-13       Impact factor: 6.600

8.  AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease.

Authors:  Tyler B Johnson; Katherine A White; Jon J Brudvig; Jacob T Cain; Logan Langin; Melissa A Pratt; Clarissa D Booth; Derek J Timm; Samantha S Davis; Brandon Meyerink; Shibi Likhite; Kathrin Meyer; Jill M Weimer
Journal:  Mol Ther       Date:  2020-09-24       Impact factor: 11.454

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.